Ruibo’an® Posaconazole Injection
Category: Product Showcase
【Generic Name】
Posaconazole Injection
【Indications】
1. Treatment of Invasive Aspergillosis
For the treatment of invasive aspergillosis in patients aged 13 years and older.
2. Prevention of invasive aspergillosis and candidiasis
It is indicated for children aged 2 years and older and for adults who are at increased risk of these infections due to severe immunodeficiency, such as patients who have developed graft-versus-host disease (GVHD) following hematopoietic stem cell transplantation (HSCT) or patients with hematologic malignancies who experience prolonged neutropenia as a result of chemotherapy.
【Specification】
16.7 ml: 0.3 g
【National Drug Approval Number H20233490】
For more information, please refer to the instruction manual.
Keywords: Ruibo’an® Posaconazole Injection
Previous: Voriconazole Tablets, VORICONAZOLE
Related Products
Product Inquiry
Please provide the product information you’d like to inquire about, and we will contact you as soon as possible.
Sunshine Avenue, Sunshine Third Road, Miaoshan Subdistrict, Economic Development Zone, Jiangxia District, Wuhan, Hubei Province
QR code
Copyright © Wuhan Qirui Pharmaceutical Co., Ltd. |Privacy Policy
Powered by www.300.cn
This website supports IPv6.